ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – Rare & Autoinflammatory Diseases 6 Nov 20238 Nov 2023 Gozde Kubra YardimciGozde completed her rheumatology fellowship at Hacettepe University Medical Faculty in Ankara, and has started her VCRC-Vasculitis Foundation Fellowship. She is currently working as a clinical & research fellow at…
ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – Imaging 6 Nov 20238 Nov 2023 Féline KroonFéline is a rheumatologist-in-training at Zuyderland Medical Center in Heerlen (The Netherlands). She did her PhD on treatment and outcome measurement in hand osteoarthritis at the Leiden University Medical Center in Leiden. Féline is a…
ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – Paediatric Rheumatology 6 Nov 20238 Nov 2023 Sónia Melo GomesSónia is a Clinical Research Fellow who recently finished her PhD in genetics of Autoinflammation at the UCL GOSH Institute of Child Health in London, UK. She is…
ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – Health Professionals in Rheumatology 6 Nov 20238 Nov 2023 Simone BattistaSimone is a Physiotherapist, Research Fellow at the University of Genova (Italy) and Affiliated Researcher at Lund University (Sweden). He is interested in chronic rheumatic and musculoskeletal diseases (RMD)…
Rare and Autoinflammatory Diseases [ACR22] Rare and Autoinflammatory Diseases 29 Nov 20226 Dec 2022 Author: Francesca Crisafulli Direskeneli et al. (2231) retrospectively investigated the rate of new major organ involvement and/or relapses during follow-up in 440 patients with Behçet disease (BD) under immunosuppressive treatment…
Basic Research [ACR22] Basic Research 29 Nov 20226 Dec 2022 Author: Silvia Piantoni Izuka et al (0586) proposed a new approach of classification of the systemic immune-mediated diseases based on the associated immune cells, detected by flow cytometry. They have…
Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) [ACR22] Systemic Lupus Erythmatosus and Antiphospholipid Syndrome 29 Nov 20226 Dec 2022 Author: Cristiana Sieiro Santos Luong et al. (0320) described the use of metabolomic analysis of metabolites to identify biomarkers of disease activity or adverse pregnancy outcomes (APO) in SLE. Low-density…
Imaging [ACR22] Imaging 29 Nov 20226 Dec 2022 Author: Manouk de Hooge Wittoek et al. (2207) investigated the structural sonographic features of joints and tendons (right shoulder, hip, knee, ankle, first metatarsophalangeal joint (MTP1), elbow, wrist and second…
Rheumatoid arthritis II - therapeutic [ACR22] Rheumatoid Arthritis II – Clinical (Therapeutic) 29 Nov 20226 Dec 2022 Author: Daliya Pencheva Emery et al (L03) introduced the concept of stimulating human programmed cell death protein 1 (PD-1) as a new rheumatoid arthritis (RA) treatment. In a Phase 2a,…
Rheumatoid Arthritis [ACR22] Rheumatoid Arthritis I – Clinical (Non-therapeutic) 29 Nov 20226 Dec 2022 Author: Emanuele Bozzalla Cassione Leuchten et al (0265) analyzed the impact of synovitis in ankle and MTP joints on RA score and disease activity states across 7,577 visits. Foot joints…